Stock Market News2 weeks BioMarin to Report Q4 Earnings: Here’s What to Expect Zacks
When BMRN reports fourth-quarter earnings, investors will likely focus on the sales performance of its dwarfism drug Voxzogo.
Biomarin Pharma (BMRN) · Earnings
XWhen BMRN reports fourth-quarter earnings, investors will likely focus on the sales performance of its dwarfism drug Voxzogo.
Biomarin Pharma (BMRN) · Earnings
X